Repligen posted solid growth and beat Wall Street's sales and adjusted earnings estimates.

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

Equity analysts in Manhattan have a difficult time imagining the logistics needs in Brazil. In this podcast, Motley Fool ...

Moving forward, Shift4 Payments has raised its guidance for key financial metrics, including its gross revenue less network ...

Jefferies analyst Greg Konrad downgraded AeroVironment stock from buy to hold today. Shares of the military drone maker have ...

Total revenue for Q3 was $13.5 million, missing the $16.2 million analyst estimate. Operating expenses dropped by 24%, ...

Many or all of the products here are from our partners that compensate us. It’s how we make money. But our editorial ...

Lucid reported third-quarter financial results last week and had a net loss of $992 million. The company is trying to ...

The meat industry powerhouse reported a strong bottom-line recovery, with profitability rebounding in key segments.

Home Depot reported decent revenue growth for Q3 thanks, in part, to hurricane activity, but it experienced a decline in net ...

Cronos Group ( CRON 12.13%) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 ...

These stocks will help you profit from the AI boom.